This reduced serum MG53 level could be due to muscle atrophy in later stage of disease, perhaps combined with diminished MG53 secretion due to the pathological aggregation we observed with disease progression in the ALS mice. Here, TRIM72 is linked to amyotrophic lateral sclerosis.